Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardiology
Cardiac Science Reports Record Results for Second Quarter of 2007
August 18th, 2007
Cardiac Science Corporation (NASDAQ:CSCX), a global leader in external cardiac monitoring and defibrillation products, announced strong results for the second quarter ended June 30, 2007. Revenue for the quarter was $44.9 million, an increase of 14.5% over the prior year period. The growth reflected a 39% increase in defibrillation sales, partially offset by a 6% decline in cardiac monitoring sales from the second quarter of 2006. Defibrillation was driven by domestic AED sales, which rose 83% from the prior year's second quarter and 31% sequentially over first quarter of 2007, illustrating continued momentum and gains in market share. Cardiac monitoring revenue...
Source: Law & Health Weekly (2007-08-18)
|
